Skip to main content

Month: September 2020

Altimmune to Present at Upcoming Investor Conferences

GAITHERSBURG, Md., Sept. 30, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that management will present at the following upcoming virtual investor conferences in October:H.C. Wainwright 4th Annual NASH Investor ConferenceMonday, October 5, 2020 – 3:30 pm ETGuggenheim Securities’ 1st Annual Vaccines & Infectious Diseases DayMonday, October 5, 2020 – 4:45 pm ETThe H.C. Wainwright presentation will be webcast and can be accessed by visiting the investor relations section of the company’s website at www.altimmune.com under Events/Presentations.About AltimmuneAltimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. The Company’s diverse pipeline includes...

Continue reading

XPO Logistics Wins Two Awards for Excellence from Whirlpool Corporation

GREENWICH, Conn., Sept. 30, 2020 (GLOBE NEWSWIRE) —  XPO Logistics, Inc. (NYSE: XPO), a leading global provider of transportation and logistics solutions, has received two awards from Whirlpool Corporation for outstanding supply chain performance in North America. XPO has been named Whirlpool Corp.’s Intermodal Carrier of the Year for consistently demonstrating intermodal and drayage excellence, and has received the Maytag Dependability Award for superior results in reverse logistics.“We’re proud to receive such high honors from Whirlpool for supporting multiple parts of their supply chain,” said Troy Cooper, president of XPO Logistics. “I applaud our intermodal and logistics teams for their fierce commitment to excellence. We’re delivering efficiencies that benefit Whirlpool’s operations and flow through to their customers.”Christy...

Continue reading

Sensyne Health Full Year Results

Sensyne HealthFull Year ResultsOxford, U.K. 30 September 2020: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the UK Clinical AI company, today announces its audited full year results for the 12 months ended 30 April 2020.Lord (Paul) Drayson PhD, CEO of Sensyne Health, said:“Sensyne has made significant commercial and technological progress in the past 12 months, despite a number of challenges and the dramatic changes triggered by COVID-19. I am particularly proud of how the Company has developed solutions to some of the challenges that have arisen during the course of the pandemic. Sensyne’s achievements over the past year highlight the dedication and proficiency of our employees who are committed to supporting the Company’s mission to improve patient care and accelerate pharmaceutical research.Recent developments...

Continue reading

Indiva Ships Wana™ Sour Gummies to Alberta, Saskatchewan, and Yukon Territory

Not for Distribution to US Newswire Services or Dissemination in the United StatesLONDON, Ontario, Sept. 30, 2020 (GLOBE NEWSWIRE) — Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF), the parent company of Indiva Inc. (the “Company” or “Indiva”), a leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce that the first three flavours of Wana™ Sour Gummies have shipped to Alberta, Saskatchewan, and Yukon Territory. Mango Sativa (5 mg THC per gummie), Watermelon Hybrid (5 mg THC per gummie), and Strawberry Lemonade 1:1 (5 mg THC, 5 mg CBD per gummie) are expected to be in stores this week.“We’re thrilled to have shipped Wana™ Sour Gummies to Alberta, Saskatchewan, and Yukon Territory, increasing Wana™’s presence to four provinces and one territory,” said Niel Marotta, President and Chief Executive Officer...

Continue reading

Wesdome Announces Exploration Drilling At The Eagle River Mine Extends High Grade At Falcon 7 Zone Adjacent To Mine Workings

TORONTO, Sept. 30, 2020 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX: WDO) (“Wesdome” or the “Company”) today announces results from the ongoing underground exploration drilling program at the Company’s wholly-owned Eagle River Mine in Wawa, Ontario.Although exploration drilling is currently operating at a reduced capacity due to COVID-19 restrictions, three underground drills and one surface drill are in operation. One drill continues to better define and extend the down plunge extension of the Falcon 7 Zone. The Falcon 7 Zone was originally discovered from surface drilling located in volcanic rocks approximately 200 metres (“m”) west of the mine diorite (see press release dated June 6, 2019). It is interpreted that the Falcon 7 Zone now extends from surface down a steep easterly plunge approximately 1,000 m and is part of the...

Continue reading

Arrow Exploration Confirms Issuance of Stock Options

CALGARY, Alberta, Sept. 30, 2020 (GLOBE NEWSWIRE) — ARROW Exploration Corp. (“Arrow” or the “Company”) (TSXV:AXL) announces the issuance of 3,944,000 stock options (“Options”) pursuant to the Company’s Stock Option Plan (the “Plan”).The Plan is intended to assist in attracting, retaining, engaging and rewarding directors, officers, employees and consultants of the Company, provide additional incentive to these people for their efforts on behalf of the Company, and to align with the enhancement of shareholder value. Under the Plan, the Company is able to issue Options to a maximum of 10% of the number of issued and outstanding common shares in the Company from time to time.The Options have a strike price of CAD$0.05 and have various expiries ranging from March 20, 2030 to June 18, 2030. The Options vest in thirds, with one third...

Continue reading

Iterum Therapeutics Announces Positive Pre-NDA Meeting with FDA for Sulopenem for Treatment of Uncomplicated Urinary Tract Infections

–Preparing to Submit NDA in Q4–DUBLIN, Ireland and CHICAGO, Sept. 30, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that, based on discussions at a pre-NDA meeting with the U.S. Food and Drug Administration (“FDA”), it plans to proceed with an NDA submission for sulopenem etzadroxil/probenecid, a bilayer tablet, for the treatment of uncomplicated urinary tract infections (uUTI) in patients with a quinolone-resistant pathogen.“We are pleased with the collaborative tone of our meeting with the FDA, and we believe that we now have a solid understanding of the...

Continue reading

Stingray Business and Space Factory Media Announce Strategic Partnership

MONTREAL, Sept. 30, 2020 (GLOBE NEWSWIRE) — Stingray (TSX: RAY. A; RAY. B), a leading music, media and technology company, today announced that its commercial services division, Stingray Business has signed an agreement with California-based Space Factory Media to represent Stingray products and services for in-store music, digital experiences and AI-driven consumer insights for brands and businesses. Brands today expect more from media experiences, and this new partnership seeks to provide a deeper, cross-platform offering with meaningful connections to consumers. The deal also includes an exclusive option for Stingray to acquire Space Factory Media at a pre-determined purchase price.With a team of experienced industry professionals, Space Factory will expand Stingray Business’s reach globally and will deliver business planning,...

Continue reading

Stingray Affaires et Space Factory Media annoncent leur nouveau partenariat

MONTRÉAL, 30 sept. 2020 (GLOBE NEWSWIRE) — Le Groupe Stingray Inc. (TSX : RAY.A; RAY.B), un chef de file de la musique, des médias et de la technologie, a annoncé aujourd’hui que Stingray Affaires, sa division des services commerciaux, a conclu une entente avec Space Factory Media visant l’offre sur le marché américain de ses solutions musicales en magasin, de ses expériences numériques et de ses outils de connaissance du consommateur propulsés par intelligence artificielle destinés aux marques et aux entreprises. À une époque où les attentes des marques envers les expériences multimédias sont de plus en plus élevées, ce nouveau partenariat donnera aux entreprises l’accès à une offre multiplateforme exhaustive qui leur permettra de tisser des liens encore plus forts avec le consommateur. L’entente comprend également une option d’acquisition...

Continue reading

PCS Edventures! Provides Operational Update

BOISE, Idaho, Sept. 30, 2020 (GLOBE NEWSWIRE) — PCS Edventures!, Inc., (PCSV) a leading provider of K-12 Science, Technology, Engineering, Arts, and Mathematics (STEAM) education programs and drone products, today announced the following updates on its operations:The Company has received its first order for BrickLAB STEAMventures, the Company’s recently released STEAM learning solution developed for the K-3 market. Designed as a magazine series, each issue is full of enriching STEAM challenges, activities, experiments, and stories to ignite a lifelong love of STEAM. The magazines are paired with a set of BrickLAB bricks (custom LEGO®-compatible building manipulatives) for instant hands-on STEAM learning. Each issue also includes an Educator Guide with resources to support family engagement, and options for extended learning to keep...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.